Patent details
EP2506010 Title: VEGF polymorphisms and anti-angiogenesis therapy
Basic Information
- Publication number:
- EP2506010
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP111790259
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- VEGF polymorphisms and anti-angiogenesis therapy
- French Title of Invention:
- Polymorphismes VEGF et thérapie anti-angiogenèse
- German Title of Invention:
- VEGF-Polymorphismen und Anti-Angiogenesetherapie
- SPC Number:
Dates
- Filing date:
- 26/11/2008
- Grant date:
- 17/06/2015
- EP Publication Date:
- 17/06/2015
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 03/10/2012
- EP B1 Publication Date:
- 17/06/2015
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 26/11/2015
- Expiration date:
- 26/11/2028
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 26/11/2008
- Name:
- Genentech Inc.
- Address:
- 1 DNA Way, South San Francisco, CA 94080, United States (US)
Inventor
1
- Name:
- Schneider Bryan P
- Address:
- United States (US)
2
- Name:
- Sledge George W.
- Address:
- United States (US)
3
- Name:
- Radovich Milan
- Address:
- United States (US)
Priority
1
- Priority Number:
- 991616 P
- Priority Date:
- 30/11/2007
- Priority Country:
- United States (US)
2
- Priority Number:
- 38699 P
- Priority Date:
- 21/03/2008
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- G01N 33/50;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|